HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nahin, R. L. Search for Related Content PubMed PubMed Citation Articles by Nahin, R. L. Related Collections Related Articles

Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine

National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland, USA

Correspondence: Senior Advisor for Scientific Coordination and Outreach, National Center for Complementary and Alternative Medicine, National Institutes of Health, 9000 Rockville Pike, Bldg. 31, Room 2B-11, Bethesda, MD 20892-2182, USA. E-mail: nahinr{at}mail.nih.gov

As part of its planning process, the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health, periodically evaluates how well it applies its criteria for setting research priorities. For its most recent evaluation, NCCAM compared funding levels in fiscal years 2000 and 2003 for 18 diseases with a substantial public health burden including Alzheimer’s disease, arthritis, back pain, cancer, diabetes, coronary heart disease, HIV/AIDS, migraine, and stroke, with 7 measures of disease burden: 1) prevalence, 2) mortality, 3) years of life lost (YLL), 4) years lost to disability (YLD), 5) disability-adjusted life years (DALY’s), 6) direct costs of illness (COI), and 7) total COI. There is an increasing relationship between NCCAM research funding and disease burden over the 4-year study period that reflects funding of specific research initiatives. The strength of the individual correlations varied among measures, with the strongest correlations seen with total COI and the weakest seen with mortality. When applied with its other criteria, measures of disease burden aid identification and matching of NCCAM priorities with levels of support.—Nahin, R. L. Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine.

Key Words: disease burden • NCCAM funding • public health

Related Articles

Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin

Kelvin J. A. Davies, Gennady Ermak, Beverley A. Rothermel, Melanie Pritchard, Joseph Heitman, Joohong Ahnn, Flavio Henrique-Silva, Dana Crawford, Silvia Canaider, Pierluigi Strippoli, Paolo Carinci, Kyung-Tai Min, Deborah S. Fox, Kyle W. Cunningham, Rhonda Bassel-Duby, Eric N. Olson, Zhuohua Zhang, R. Sanders Williams, Hans-Peter Gerber, Mercè Pérez-Riba, Hisao Seo, Xia Cao, Claude B. Klee, Juan Miguel Redondo, Lois J. Maltais, Elspeth A. Bruford, Sue Povey, Jeffery D. Molkentin, Frank D. McKeon, Elia J. Duh, Gerald R. Crabtree, Martha S. Cyert, Susana de la Luna, and Xavier Estivill
FASEB J 2007 21: 3023-3028. [Full Text] [PDF]